Table 1.
Baseline characteristics
| Variable | Total n = 28 |
3D CT overlay n = 14 |
Pulmonary Venography n = 14 |
p-value |
|---|---|---|---|---|
| Age (years) | 57.3 ± 8.9 | 58.2 ± 7.6 | 56.5 ± 10.3 | ns |
| Gender (male) | 20 (71.4%) | 9 (64.3%) | 11 (78.6%) | ns |
| CHADS2-VASc score | 0.8 ± 1.1 | 0.7 ± 0.7 | 0.9 ± 1.4 | ns |
| Hypertension | 6 (21.4%) | 3 (21.4%) | 3 (21.4%) | ns |
| Smoking | 8 (28.6%) | 1 (7.1%) | 7 (50.0%) | 0.011 |
| Diabetes | 0 (0%) | 0 (0%) | 0 (0%) | – |
| AF family history <65 years | 9 (32.1%) | 3 (21.4%) | 6 (42.9%) | ns |
| CAD | 0 (0%) | 0 (0%) | 0 (0%) | – |
| CHF | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | – |
| Endurance sports | 3 (10.7%) | 2 (14.3%) | 1 (7.1%) | ns |
| OSAS | 1 (3.6%) | 0 (0.0%) | 1 (7.1%) | ns |
| TIA/CVA | 1 (3.6%) | 0 (0.0%) | 1 (7.1%) | ns |
| Flutter | 3 (10.7%) | 2 (14.3%) | 1 (7.1%) | ns |
| Anticoagulants | 9 (32.1%) | 6 (42.9%) | 3 (21.4%) | ns |
| No ECV | 1.2 ± 1.9 | 1.0 ± 1.7 | 1.4 ± 2.1 | ns |
| BMI | 26.8 ± 3.0 | 26.3 ± 2.6 | 27.2 ± 3.4 | ns |
| LA volume (cc/m2) | 25.1 ± 7.2 | 25.1 ± 6.2 | 25.1 ± 8.3 | ns |
Data are expressed in mean ± SD or absolute number and percentage
AF Atrial fibrillation, CAD Coronary artery disease, CHF Congestive heart failure (Ejection Fraction <40%), OSAS Obstructive sleep apnoea syndrome, TIA Transient ischaemic attack, CVA Cerebral vascular attack, ECV Electrical cardioversion, BMI Body mass index, LA Left atrium, NS Not significant